Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up.
Abstract
PURPOSE
Long-term persistence of use, lack of co-prescribed anticholinergic antiparkinson drugs and low mortality may indicate effectiveness
and safety of antipsychotic drugs. We aimed to assess 3-year prescription persistence, concomitant use of anticholinergics
and mortality related to the use of all antipsychotic agents available in Norway.
METHODS
Data were drawn from the Norwegian Prescription Database on the sales of antipsychotic and anticholinergic antiparkinson agents
in 2004 to a total of 52,427 patients. The primary study group was a subgroup of 34,494 patients who were prescribed only
one antipsychotic agent in 2004. The patients were re-investigated in 2007. For each of the 13 antipsychotic agents studied,
assumed prescription persistence was assessed in light of use of anticholinergic antiparkinson agents in 2004, and casualty
rates were noted.
RESULTS
The highest persistence was demonstrated for zuclopenthixol (69.8%) and clozapine (88.4%). Zuclopenthixol was often co-prescribed
with anticholinergics (22.2%), in contrast to clozapine (3.6%). Ziprasidone was associated with a low mortality (OR = 0.08),
while chlorprotixene and haloperidol were associated with a high mortality (OR = 1.34 and 3.97, respectively) compared to
levomepromazine.
CONCLUSIONS
Clozapine demonstrated a high degree of continuity of prescription and a low level of concomitant use of anticholinergics.
Zuclopenthixol also demonstrated a high degree of continuity of prescription, despite a considerable degree of co-prescribed
anticholinergics. We did not find that any antipsychotic other than ziprasidone was associated with a low mortality. The use
of haloperidol seemed to confer a mortality risk three times that of any of the other antipsychotic agents included.
Links
Authors
Gjerden P, Slørdal L, Bramness JG
Institution
Department of Psychiatry, Telemark Hospital, Skien, Norway. pal.gjerden@sthf.no
Source
European journal of clinical pharmacology 66:9 2010 Sep pg 911-7MeSH
AdultAged
Antiparkinson Agents
Antipsychotic Agents
Chlorprothixene
Cholinergic Antagonists
Clopenthixol
Clozapine
Drug Prescriptions
Female
Follow-Up Studies
Haloperidol
Humans
Logistic Models
Male
Methotrimeprazine
Middle Aged
Mortality
Norway
Odds Ratio
Piperazines
Registries
Thiazoles
Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
20521034
Log In

